Did You Know...
...that Robert Adler has the dubious distinction of being the Father of the Couch Potato? Back in 1955 Adler was employed by what was then Zenith Radio Corp., where he was charged to invent something that would allow viewers to turn down the TV volume without leaving their chairs. After a series of flops (such as a wired contraption that people tripped over), Adler hit on the idea of using sound waves. Thus the Remote Control was born...
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 6534475 | Use of TIMP-3 inducers of TIMP-3 expression, and TIMP-3 mimetics to treat ocular neovascularization Methods and compositions for treating ocular neovascularization with TIMP-3, TIMP-3 inducers, and TIMP-3 mimetics are disclosed.... | 03/18/2003 |
| 6500831 | Non-peptide bradykinin receptor antagonists for use in controlling intraocular pressure and treating glaucoma This invention relates to the topical ocular use of non-peptide bradykinin receptor antagonists to treat glaucoma and ocular hypertension.... | 12/31/2002 |
| 6399107 | Use of inhibitors of gag synthesis for the treatment of corneal haze This invention relates to the compositions and methods for the treatment of corneal haze. The compositions and methods are particularly directed to the use of GAG synthesis inhibitors in the treatment of corneal haze.... | 06/04/2002 |
| 6177427 | Treatment of glaucoma and ocular hypertension Compositions of non-steroidal glucocorticoid antagonists for treating glaucoma or ocular hypertension and methods for their use are disclosed.... | 01/23/2001 |
| 6172054 | Combination therapy for lowering and controlling intraocular pressure Angiostatic agents and another IOP lowering compound are combined in ophthalmic compositions to treat glaucoma and ocular hypertension. Methods for treating glaucoma and ocular hypertension are also disclosed.... | 01/09/2001 |
| 6090798 | Treatment of GLC1A glaucoma with glucocorticoid antagonists Compositions of glucocorticoid antagonists for treating mammals suffering from GLC1A glaucoma and methods for their use are disclosed.... | 07/18/2000 |
| 6071904 | Process for manufacturing ophthalmic suspensions Ophthalmic suspensions containing brinzolamide or brinzolamide and a beta-blocker and processes for manufacturing the suspensions are disclosed.... | 06/06/2000 |
| 6071875 | TGF for the treatment of ocular hypertension and glaucoma Compositions and methods for treating glaucoma and ocular hypertension by using TGF are disclosed.... | 06/06/2000 |
| 6066671 | Treatment of GLC1A glaucoma with 3-benzoyl-phenylacetic acids, esters, or amides Compositions of 3-benzoylphenylacetic acid derivatives for treating GLC1A glaucoma and methods for their use are disclosed.... | 05/23/2000 |
| 6051611 | Polymeric quaternary ammonium compounds and their use as ophthalmic antimicrobias The invention relates to polymeric quaternary ammonium compounds which are useful as disinfectants and/or preservatives in ophthalmic compostions.... | 04/18/2000 |
| 6051573 | Treatment of GLC1A glaucoma with non-steroidal glucocorticoid antagonists Compositions of non-steroidal glucocorticoid antagonists for treating GLC1A glaucoma and methods for their use are disclosed.... | 04/18/2000 |
| 6020352 | Treatment of ischemic disorders of the retina and optic nerve head The use of polyamine site antagonists in treating ischemic disorders of the retina and optic nerve head are disclosed. Especially preferred are certain 1-phenyl-2-piperidinoalkanol derivatives, such as eliprodil and ifenprodil.... | 02/01/2000 |
| 6011023 | Angiostatic steroids Methods and compositions for preventing and treating neovascularization with steroids is disclosed.... | 01/04/2000 |
| 5990099 | Angiostatic agents and methods and compositions for controlling ocular hypertension Compositions of angiostatic agents for treating GLC1A glaucoma and methods for their use are disclosed.... | 11/23/1999 |
| 5976462 | Compositions and method for disinfecting fabric Compositions for disinfecting fabric and preventing spread of contamination are disclosed. Methods for their use are also contemplated.... | 11/02/1999 |
| 5972922 | Steroids which inhibit angiogenesis Novel angiostatic Ɗ4,9(11) -steroids (I), ##STR1## C21 -oxygenated steroids (II) and other known steroidal compounds have been found to be useful in treating angiogenesis in mammals who have a need for the same. These steroids ... | 10/26/1999 |
| 5948801 | Treatment of retinal edema with brinzolamide Methods for preventing and treating retinal edema with brinzolamide are disclosed.... | 09/07/1999 |
| 5932572 | Topical anti-glaucoma compositions Ophthalmic pharmaceutical compositions useful in controlling elevated intraocular pressure associated with glaucoma and ocular hypertension are described. The compositions comprise a combination of a beta-blocker and a carbonic anhydrase inhibitor to redu... | 08/03/1999 |
| 5883108 | Combination therapy for treating glaucoma Methods for treating persons with glaucoma or ocular hypertension with polyamine antagonists and an IOP-lowering compounds are also disclosed.... | 03/16/1999 |
| 5770592 | Prevention and treatment of ocular neovascularization using angiostatic steroids Methods and formulations for treating ocular neovascularization using angiostatic steroids are disclosed.... | 06/23/1998 |
| 5710165 | Use of polyamine antagonists for the treatment of glaucoma Polyamine antagonists are found to be effective in preventing or reducing visual field loss associated with glaucoma. Especially preferred are certain 1-phenyl-2-piperidinoalkanol derivatives, such as eliprodil and ifenprodil.... | 01/20/1998 |
| 5700794 | Treatment of ocular hypotony Methods for treating ocular hypotony are disclosed.... | 12/23/1997 |
| 5698545 | Angiostatic steroids and methods and compositions for controlling ocular hypertension Angiostatic steroids for use in controlling ocular hypertension are disclosed. Pharmaceutical compositions of the angiostatic steroids and methods for their use in treating ocular hypertension, including controlling the ocular hypertension associated with... | 12/16/1997 |
| 5686407 | Hepatocyte growth factor to treat glaucoma Methods for controlling IOP with compositions of HGF Receptor Activators are disclosed.... | 11/11/1997 |
| 5681854 | Use of aliphatic carboxylic acid derivatives in ophthalmic disorders The use of certain aliphatic carboxylic acid derivatives to treat persons suffering from retinal or optic nerve head damage is disclosed.... | 10/28/1997 |
| 5681834 | Heterocyclic sulfonamides Compounds of the following structure are disclosed: ##STR1## Wherein G, J and the two atoms of the thiophene ring to which they are attached are the group ##STR2##... | 10/28/1997 |
| 5679666 | Prevention and treatment of ocular neovascularization by treatment with angiostatic steroids Methods and formulations for treating ocular neovascularization using angiostatic steroids are disclosed.... | 10/21/1997 |
| 5679336 | Antibacterial compositions Aqueous pharmaceutical compositions containing a synergistic combination of a quinolone and a polystyrene sulfonic acid polymer are described, wherein the compositions are clear solutions which are comfortable and have sustained release. Methods for use o... | 10/21/1997 |
| 5679670 | Sulfonamides useful as carbonic anhydrase inhibitors Sulfonamides and pharmaceutical compositions containing the compounds useful in controlling intraocular pressure are disclosed. Methods for controlling intraocular pressure through administration of the compositions are also disclosed.... | 10/21/1997 |
| 5677335 | 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for the treatment of ocular disease The use of 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for treating ocular diseases with immune etiology is disclosed.... | 10/14/1997 |
| 5668133 | Ophthalmic compositions comprising emedastine and methods for their use Topical ophthalmic compositions comprising 1-(2-ethoxyethyl)-2-(4-methyl-1-homopiperazinyl)-benzimidazole and its ophthalmically acceptable acid addition salts have been found to be useful in treating ocular allergies, especially allergic conjunctivitis, ... | 09/16/1997 |
| 5646142 | Thiophene sulfonamides useful as carbonic anhydrase inhibitors New thiophene sulfonamides useful as carbonic anhydrase inhibitors are disclosed. Methods for using the compounds to control IOP are also disclosed.... | 07/08/1997 |
| 5635172 | Sustained release comfort formulation for glaucoma therapy Disclosed are nonstinging, sustained release ophthalmic formulations to control intraocular pressure in antiglaucoma therapy comprising a basic active, a cation exchange resin, and, inter alia, an acidic, mucomimetic polymer. Also disclosed are methods of... | 06/03/1997 |
| 5620970 | Topical ophthalmic carbonic anhydrase inhibitor formulations The present invention is directed to topical ophthalmic formulations of carbonic anhydrase inhibitors and polyethoxylated derivatives of castor oil. Methods for using the formulations for treating and controlling glaucoma and ocular hypertension are also ... | 04/15/1997 |
| 5612364 | Substantially pure apraclonidine Compositions containing, and methods for controlling intraocular pressure with, substantially pure apraclonidine are disclosed.... | 03/18/1997 |
| 5604244 | Intraocular irrigating solution containing a polyamine antagonist Pharmaceutical compositions useful in ophthalmic surgery are described. The compositions include one or more polyamine antagonists, and are useful for preventing or treating excitotoxicity associated with ophthalmic surgery. Methods of using the compositi... | 02/18/1997 |
| 5585377 | Sulfonamides useful as carbonic anhydrase inhibitors Sulfonamides and pharmaceutical compositions containing the compounds useful in controlling intraocular pressure are disclosed. Methods for controlling intraocular pressure through administration of the compositions are also disclosed.... | 12/17/1996 |
| 5583150 | 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases The use of 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic acid anilides for treating ocular diseases with immune etiology is disclosed.... | 12/10/1996 |
| 5558876 | Topical ophthalmic acidic drug formulations Stable, comfortable, preserved, topical, ophthalmic compositions of acidic drugs are disclosed. Methods for their use are also disclosed.... | 09/24/1996 |
| 5554367 | Compositions for treatment of glaucoma Compositions for controlling glaucoma and ocular hypertension are disclosed.... | 09/10/1996 |
